Form EFFECT AMICUS THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016984 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MSCI Announces Second Quarter 2026 Earnings Call Details
- CCHH CEO Announces Planned Purchase of US$10 Million to US$30 Million of Company Shares at Not Less Than US$1.00 Per Share, Reinforcing Long-Term Commitment to Strategic Growth
- Medical Care Technologies Subsidiary Infinite Auctions Surges Past $158,000 in High-Profile Memorabilia Auction with Explosive Viewer Engagement
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
